Skip to main content
. 2014 Jun 1;1(2):51–54. doi: 10.5152/eurjrheumatol.2014.018

Table 1.

HBsAg and anti-HCV prevalence in RA and AS patients and general population

HBsAg n (%) Anti HCV n (%)
General population (n:5465) 218 (3.99)* 52 (0.95)
RA (n:1517) 35 (2.3) 17 (1.1)
AS (n:886) 27 (3) 10 (1.1)
*

p<0.01; * vs. RA and AS patients.

HBsAg: hepatitis B virus surface antigen; anti-HCV: hepatitis C virus antibody; RA: rheumatoid arthritis; AS: ankylosing spondylitis